NumerixS Investment Technologies’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,600	Closed	-$124K	–	296
2020 Q2	$124K	Buy	3,600 +1,300	+57%	+$44.8K	0.03%	520
2020 Q1	$51K	Buy	+2,300	New	+$51K	0.03%	602
2019 Q1	–	Sell	-300	Closed	-$4K	–	1175
2018 Q4	$4K	Buy	+300	New	+$4K	﹤0.01%	1027